Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Glioblastoma Multiforme Companies

Glioblastoma multiforme (GBM) is a highly aggressive type of brain cancer. Companies involved in glioblastoma research and treatment focus on developing therapies, diagnostic tools, and technologies to improve patient outcomes.

Glioblastoma Multiforme Key Companies

Latest Glioblastoma Multiforme Companies Update

In December 2022, the FDA granted Fast Track designation to WP1122, a novel glioblastoma treatment developed by Wolf Pharmaceuticals. This designation expedites the review process for promising new drugs, potentially bringing WP1122 to market sooner.

In November 2023, the China National Medical Products Administration (NMPA) granted marketing approval for the Optune device from NovoCure. This non-invasive therapy uses tumor treating fields (TTF) to disrupt cancer cell division and is a valuable addition to the treatment landscape for GBM patients in China.

In October 2023, Roche announced positive Phase 2 results for RO7499870, a targeted therapy aimed at a specific genetic mutation found in some GBM tumors. These results pave the way for further development of this promising treatment candidate.

List of Glioblastoma Multiforme Key Companies in the Market

Merck & Co., Inc (US)

Amgen, Inc (US)

Bristol-Myers Squibb Company (US)

Hoffmann-La Roche Ltd (Switzerland)

Novartis AG (Switzerland)

Pfizer Inc (US)

AstraZeneca (UK)

Eli Lilly and Company (US)

VBI Vaccines Inc. (US)

AbbVie Inc. (US)

Glioblastoma Multiforme Market Highlights:

Glioblastoma Multiforme Market Size

Glioblastoma Multiforme Market Trends

Glioblastoma Multiforme Market Analysis

Glioblastoma Multiforme Market Share

Glioblastoma Multiforme Market Highlights:

Glioblastoma Multiforme Market Trends

Glioblastoma Multiforme Market Analysis

Glioblastoma Multiforme Market Share

Glioblastoma Multiforme Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.